Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
PLoS One
; 13(1): e0192059, 2018.
Article
in En
| MEDLINE
| ID: mdl-29370292
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2018
Document type:
Article
Country of publication: